ALBERICI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 3.375
AS - Asia 3.074
EU - Europa 2.136
SA - Sud America 346
AF - Africa 66
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.042
Nazione #
US - Stati Uniti d'America 3.196
CN - Cina 1.135
SG - Singapore 712
IT - Italia 475
GB - Regno Unito 413
JP - Giappone 252
HK - Hong Kong 204
VN - Vietnam 200
RU - Federazione Russa 184
BR - Brasile 182
DE - Germania 173
ES - Italia 173
FR - Francia 162
IN - India 144
MX - Messico 86
IE - Irlanda 81
TR - Turchia 76
CA - Canada 68
BD - Bangladesh 64
NL - Olanda 59
SE - Svezia 59
AR - Argentina 55
ID - Indonesia 52
KR - Corea 51
CO - Colombia 46
FI - Finlandia 42
PL - Polonia 41
CH - Svizzera 39
AU - Australia 37
AT - Austria 34
GR - Grecia 27
NO - Norvegia 26
TW - Taiwan 26
CL - Cile 21
IR - Iran 20
BE - Belgio 19
DK - Danimarca 19
PT - Portogallo 19
PE - Perù 18
UA - Ucraina 18
IL - Israele 17
MA - Marocco 17
MY - Malesia 16
SA - Arabia Saudita 16
RS - Serbia 14
ZA - Sudafrica 14
EG - Egitto 13
RO - Romania 13
TH - Thailandia 13
IQ - Iraq 12
HU - Ungheria 11
PK - Pakistan 11
CI - Costa d'Avorio 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
NP - Nepal 8
HR - Croazia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 5
GT - Guatemala 5
JO - Giordania 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PH - Filippine 5
AM - Armenia 4
CR - Costa Rica 4
KE - Kenya 4
KW - Kuwait 4
PS - Palestinian Territory 4
BO - Bolivia 3
DZ - Algeria 3
EU - Europa 3
HT - Haiti 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BS - Bahamas 2
LA - Repubblica Popolare Democratica del Laos 2
QA - Qatar 2
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
Totale 9.038
Città #
Singapore 421
Ashburn 259
Southend 242
Beijing 203
Fairfield 202
Redwood City 172
Hong Kong 152
Dearborn 131
San Jose 131
Chandler 122
Santa Clara 120
Woodbridge 105
Council Bluffs 102
Milan 97
Seattle 90
Guangzhou 88
New York 84
Houston 83
Dublin 80
Cambridge 78
Los Angeles 77
Princeton 76
Tokyo 73
Dallas 72
Shanghai 72
Nanjing 71
Wilmington 70
Ann Arbor 63
Ho Chi Minh City 61
Phoenix 57
Des Moines 47
Hanoi 45
Lauterbourg 39
Moscow 39
Helsinki 37
Jakarta 36
Madrid 31
Barcelona 30
Bengaluru 30
Frankfurt am Main 28
Istanbul 28
Hangzhou 27
Hefei 27
Central District 26
Mexico City 26
Seoul 26
Shenyang 26
São Paulo 26
Buffalo 25
Columbus 25
Nanchang 25
London 24
Rome 24
The Dalles 23
Florence 21
Vienna 21
Zurich 21
Chengdu 20
Buenos Aires 19
Changsha 19
Warsaw 19
Zhengzhou 19
Jinan 18
Paris 18
Tianjin 18
Brescia 17
Orem 17
Bathinda 16
Delhi 16
Falls Church 16
Wuhan 16
Bogotá 15
Chongqing 15
Montreal 15
Mumbai 15
Athens 13
Bologna 13
Brooklyn 13
Chennai 13
Chicago 13
Riyadh 13
Santiago 13
Ankara 12
Da Nang 12
Medellín 12
Nuremberg 12
Ottawa 12
Silver Spring 12
Washington 12
Cinisello Balsamo 11
Haiphong 11
Hebei 11
Naples 11
New Delhi 11
San Diego 11
Taipei 11
Heidelberg 10
Melbourne 10
Rio de Janeiro 10
San Francisco 10
Totale 5.037
Nome #
Lupus nephritis and B-cell targeting therapy 1.471
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis 1.043
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 768
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 444
Chronic periaortitis with thoracic aorta and epiaortic artery involvement : a systemic large vessel vasculitis? 354
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 352
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature 245
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 245
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 226
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 217
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 210
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 209
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 208
Genetics of ANCA-Associated Vasculitis 192
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis : a randomised trial 187
Update on ANCA-associated vasculitis : from biomarkers to therapy 177
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 171
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 164
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN 158
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 157
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 148
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 148
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC) : a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC) 115
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 114
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 111
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis 111
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 105
The role of analytical methods for the determination of trace elements in environmental biomonitors 105
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 105
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 103
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 99
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-alpha in patients with renal cell carcinoma 97
Incremental peritoneal dialysis: less is more—for the patient and the planet 90
Rituximab-associated hypogammaglobulinemia : incidence, predictors and outcomes in patients with multi-system autoimmune disease 90
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile 89
Orofacial granulomatosis treated with low-level laser therapy: a case report 82
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial 79
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease : a case series 79
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 76
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms 75
Genetics of ANCA-associated vasculitides: HLA and beyond 73
IgG4 immune response in Churg-Strauss syndrome 72
Totale 9.364
Categoria #
all - tutte 23.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 67 68
2021/2022711 56 53 38 62 55 52 60 51 73 59 39 113
2022/2023809 107 37 27 70 80 125 33 72 127 26 65 40
2023/2024732 52 59 35 53 146 44 42 53 42 51 64 91
2024/20251.368 57 136 45 93 182 88 66 166 85 111 132 207
2025/20262.584 227 89 217 288 389 195 371 135 293 186 194 0
Totale 9.364